Nomura Micro ScienceNomura Micro Science Co.,Ltd.6254東証プライム機械FY ending Mar 2026, consolidated, J-GAAP

Nomura Micro Science revenue and profit

Out of every ¥100 of sales, about ¥12 is left as operating profit. Revenue changed -41.6% from the prior year, operating profit -56.6%.

Five-year trend

Revenue¥56.2B
FY ending Mar 2022: ¥31.9B¥31.9BFY ending Mar 2023: ¥49.6B¥49.6BFY ending Mar 2024: ¥73B¥73BFY ending Mar 2025: ¥96.4B¥96.4BFY ending Mar 2026: ¥56.2B¥56.2BFY22FY23FY24FY25FY26
Operating income¥6.67B
FY ending Mar 2022: ¥4.43B¥4.43BFY ending Mar 2023: ¥6.55B¥6.55BFY ending Mar 2024: ¥10.6B¥10.6BFY ending Mar 2025: ¥15.4B¥15.4BFY ending Mar 2026: ¥6.67B¥6.67BFY22FY23FY24FY25FY26
Operating margin11.9%
FY ending Mar 2022: 13.9%13.9%FY ending Mar 2023: 13.2%13.2%FY ending Mar 2024: 14.6%14.6%FY ending Mar 2025: 16.0%16.0%FY ending Mar 2026: 11.9%11.9%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin6.8%
Asset turnover0.50×
ROA3.4%
ROA3.4%
Financial leverage3.17×
ROE10.7%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin6.8%
2022: 10.3%10.3%2023: 11.7%11.7%2024: 10.9%10.9%2025: 10.6%10.6%2026: 6.8%6.8%2223242526
Asset turnover0.50×
2022: 1.18×1.18×2023: 1.44×1.44×2024: 1.30×1.30×2025: 1.03×1.03×2026: 0.50×0.50×2223242526
ROA3.4%
2022: 12.1%12.1%2023: 16.8%16.8%2024: 14.2%14.2%2025: 10.9%10.9%2026: 3.4%3.4%2223242526
Financial leverage3.17×
2022: 1.83×1.83×2023: 1.99×1.99×2024: 2.41×2.41×2025: 3.04×3.04×2026: 3.17×3.17×2223242526
ROE10.7%
2022: 22.2%22.2%2023: 33.5%33.5%2024: 34.2%34.2%2025: 33.1%33.1%2026: 10.7%10.7%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202210.3%1.18×12.1%1.83×22.2%
202311.7%1.44×16.8%1.99×33.5%
202410.9%1.30×14.2%2.41×34.2%
202510.6%1.03×10.9%3.04×33.1%
20266.8%0.50×3.4%3.17×10.7%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue11.1%
2021: 6.0%6.0%2022: 6.0%6.0%2023: 5.9%5.9%2024: 4.2%4.2%2025: 5.1%5.1%2026: 11.1%11.1%212223242526
PPE ÷ total assets5.7%
2021: 7.4%7.4%2022: 7.1%7.1%2023: 7.0%7.0%2024: 4.3%4.3%2025: 4.2%4.2%2026: 5.7%5.7%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥493.2M
2021: ¥188.4M¥188.4M2022: ¥207.3M¥207.3M2023: ¥256.8M¥256.8M2024: ¥341.9M¥341.9M2025: ¥381.5M¥381.5M2026: ¥493.2M¥493.2M212223242526
R&D / revenue0.9%
2021: 0.6%0.6%2022: 0.6%0.6%2023: 0.5%0.5%2024: 0.5%0.5%2025: 0.4%0.4%2026: 0.9%0.9%212223242526
Receivable days—
2021: 106d106d212223242526
Payable days65d
2021: 69d69d2022: 68d68d2023: 68d68d2024: 58d58d2025: 45d45d2026: 65d65d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue31,90149,59673,02196,36056,246
Cost of revenue24,24539,22457,61475,25043,539
Gross profit7,65710,37215,40721,11012,707
SG&A3,2233,8224,7595,7386,040
Operating income4,4336,55010,64815,3726,667
Pretax income4,5787,45010,82813,4005,646
Income tax1,2871,6442,8503,2001,828
Net income attributable to owners3,2925,8077,97810,2003,818
Operating margin13.9%13.2%14.6%16.0%11.9%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 9%
6%
0%
1%
Other assets 84%

Funding

7%
Other liabilities 57%
Equity 36%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥8.45B¥13.2B¥11.9B¥16.5B¥9.93B
Total assets¥27.1B¥41.9B¥70.6B¥116.8B¥110.3B
Net assets¥15.9B¥21.4B¥28.9B¥37B¥39.9B
Share capital¥2.24B¥2.24B¥2.24B¥2.24B¥2.24B
Property, plant and equipment¥1.92B¥2.92B¥3.06B¥4.96B¥6.26B
Intangible assets excluding goodwill¥161.2M¥133.1M¥104.8M¥119.5M¥79.8M
Investment securities¥531.5M¥533.5M¥793.6M¥846.2M¥1.06B
Current assets¥23.4B¥37.2B¥65.5B¥109B¥100B
Current liabilities¥10.7B¥20B¥41.3B¥78.9B¥68.2B
Trade payables¥4.51B¥7.34B¥9.23B¥9.25B¥7.76B
Short-term borrowings¥2.65B¥3.44B¥22.4B¥52.2B¥51.1B
Total liabilities¥11.2B¥20.5B¥41.7B¥79.8B¥70.4B
Equity attributable to owners of parent¥14.8B¥19.9B¥26.7B¥34.9B¥36.7B
Retained earnings¥10.9B¥15.7B¥22.1B¥29.7B¥30.5B
Treasury stock-¥453.6M-¥406.7M-¥372M-¥330.1M-¥278.9M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第57期(2025/04/01-2026/03/31)

    ID S100YG4U2026-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第56期(2024/04/01-2025/03/31)

    ID S100W3YM2025-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第55期(2023/04/01-2024/03/31)

    ID S100TSXZ2024-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第54期(2022/04/01-2023/03/31)

    ID S100R12E2023-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第53期(令和3年4月1日-令和4年3月31日)

    ID S100OES22022-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第52期(令和2年4月1日-令和3年3月31日)

    ID S100LOE72021-06-24Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.